Allergy immunotherapy (AIT) is an effective treatment for allergic asthma and rhinitis, as well
as venom-induced anaphylaxis. In addition to reducing symptoms, AIT can change the …

Allergen immunotherapy (AIT) has been used to treat allergic disease since the early 1900s.
Despite numerous clinical trials and meta-analyses proving AIT efficacious, it remains …

Allergen-specific immunotherapy is a potentially disease-modifying therapy that is effective
for the treatment of allergic rhinitis/conjunctivitis, allergic asthma and stinging insect …

This article continues the comprehensive international consensus (ICON) statement on
allergen immunotherapy (AIT). The initial article also recently appeared in the Journal. The …

Allergen-specific immunotherapy (AIT), although in clinical use for more than a century, is
still the only causal treatment of allergic diseases. The safety and efficacy of AIT has been …

Subcutaneous immunotherapy and sublingual immunotherapy are beneficial in treating
allergic rhinitis and venom hypersensitivity but should be administered only by physicians …

Allergen immunotherapy has been used to treat allergic diseases, such as asthma, allergic
rhinitis, and venom allergy, since first described over a century ago. The current standard of …

Allergen immunotherapy is the practice of administering gradually increasing quantities of
an allergen extract to an allergic subject to ameliorate the symptoms associated with the …

Allergen immunotherapy (AIT) is a safe, effective treatment for allergic rhinoconjunctivitis
and allergic asthma. However, AIT's clinical effect is still contested—primarily due to …

Allergen immunotherapy continues to be used worldwide in the management of allergic
rhinitis and asthma. We continue to refine our knowledge of the indications for …